Site Network: Australia | New Zealand | South Africa |


Acquisition of Oral Antibiotics from CSL
Wednesday, 27 June 2007 - Aspen Australia

Aspen Pharmacare Australia are pleased to announce the acquisition of the following oral antibiotics as from the 2nd of July:

LPV Phenoxymenthyl-penicillin capsules (250mg and 500mg
FLOPEN Flucloxacillin capsules (250mg and 500mg)
FLOPEN Flucloxacillin oral suspension (125mg/5ml and 250mg/5ml)
MOXACIN Amoxycillin capsules (250mg and 500mg)
MOXACIN SUGAR FREE Amoxycillin oral suspension (125mg/5ml and 250mg/5ml)

As from the 2nd of July 2007 Aspen will take over all sales, marketing and distribution for these products.


Related Articles :
Search Articles :